Skip to content
Peregrine
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact

News

BioProtect Balloon ImplantTM System has been cleared by the FDA

Read More
Cordio Medical

AstraZeneca launches pilot program for Cordio Medical

Read More

KAHR Medical reports dose escalation data from its Phase I trial of DSP107

Read More

“It’s a simple daily habit that could save their life” – Cordio Medical coverage in Forbes magazine

Read More

Ribon Therapeutics announced dosing of the first patient

Read More

Restore announces successful First-In-Human preliminary results of Its CONTRABAND™ system

Read More

BioProtect presented successful outcomes from its phase I/II study

Read More

Levation Pharma, Ltd. received an FDA clearance to initiate Phase I/II of LEV102

Read More

EndoStream Medical announced they are conducting their first case in the US as part of the company’s Clinical Trial

Read More

Nectin Therapeutics announced a mutual clinical trial with Merck

Read More
Page1 Page2 Page3 Page4 Page5
  • Home
  • About Us
    • Company Overview
    • Our Mission
  • Our Funds
  • Portfolio
  • Team
  • ESG & Impact
  • News
  • Contact
Linkedin-in
©All rights reserved to Peregrine 2025

site by: 

razgroup-logo